Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Himanshu Nagar

GU Rad Onc · MSK

View

Dr. Drew Moghanaki

Thoracic Rad Onc · UCLA

View

Dr. Michael Dykstra

General Rad Onc · UM

View

Dr. Lori Pierce

Breast Rad Onc · UM

View

Dr. William Hwang

GI Rad Onc · MGH

View

Dr. Kamran Ahmed

Breast Rad Onc · Moffitt Cancer Center

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Richard Dutton

General Anesthesiology · UMSOM

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JJDr. James Janopaul-Naylor
    Leading Voice

    Dr. James Janopaul-Naylor

    Radiation Oncology · Genitourinary Radiation Oncology
    Memorial Sloan Kettering Cancer Center
    jamesjanopaulnaylor

    Research

    Patient-Facility Distance and Adjuvant Radiotherapy for WHO Grade 2-3 Meningioma

    2026

    Via American Journal of Clinical Oncology

    Research

    Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer

    2026

    Via Nature Reviews Urology

    Research

    Linac-based stereotactic radiosurgery for brain metastases: Survival and salvage treatment in a contemporary cohort of 3893 patients

    2026

    Via Neuro-Oncology Advances

    Research

    Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis

    2026

    Via Urologic Oncology: Seminars and Original Investigations

    Research

    Interpretable machine learning identifies health system levers for survival outcomes of patients with prostate cancer

    2026

    Via Prostate Cancer and Prostatic Diseases

    Research

    Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in th

    2026

    Via BMJ Open

    Research

    Neurocognitive Function and Quality of Life After Multifraction Radiosurgery for Large Resected and Intact Brain Metastases: Results of a Prospective Clinical Trial

    2025

    Via Advances in Radiation Oncology

    Research

    Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening in 2012.

    2025

    Via Cancer Medicine

    Research

    Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate Cancer.

    2025

    Via Cancers

    Research

    Impact of Systemic and Radiation Therapy on Survival of Primary Central Nervous System Lymphoma.

    2025

    Via Cancers

    Research

    A balancing ACT: maximizing the benefits of appropriate brain radiation therapy.

    2025

    Via The Lancet Regional Health Europe

    Research

    Modifiable Cardiovascular Risk Factors Amongst Men With and Without Prostate Cancer in a Large, Prospective Registry.

    2025

    Via Clinical Genitourinary Cancer

    Research

    Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States.

    2025

    Via JCO Precision Oncology

    Research

    Patterns of Treatment Failure in Primary Central Nervous System Lymphoma.

    2024

    Via American Journal of Clinical Oncology

    Research

    Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial.

    2024

    Via Head & Neck